Nurse Practitioner, Family · Dinuba, CA
NPI
1033405337
Since 2011
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
888 N Alta Ave
Dinuba, CA, 93618
Phone (559) 595-1000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.7M
10,058 prescriptions
Company payments, 2025
$3,385
From 25 companies
Medicare prescription drug claims, 2024
In 2024, the drug Isabel Y Lee prescribed most often to Medicare patients was Rosuvastatin Calcium, with 470 prescriptions and refills. In total Isabel Y Lee wrote 10,058 Medicare prescriptions that cost $2.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Rosuvastatin Calcium Generic | 470 | 1,297 | 152 | $12K |
| Lisinopril Generic | 446 | 1,182 | 145 | $3,273 |
| Amlodipine Besylate Generic | 427 | 1,114 | 134 | $2,239 |
| Metformin Hcl Generic | 403 | 1,024 | 125 | $2,633 |
| Atorvastatin Calcium Generic | 384 | 1,043 | 135 | $3,657 |
| Repatha Sureclick Evolocumab | 362 | 583 | 92 | $320K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 334 | 368 | 107 | $12K |
| Omeprazole Generic | 276 | 679 | 95 | $3,216 |
| Levothyroxine Sodium Generic | 263 | 697 | 74 | $2,545 |
| Ibuprofen Generic | 250 | 288 | 74 | $2,185 |
| Vascepa Icosapent Ethyl | 219 | 476 | 67 | $172K |
| Ozempic Semaglutide | 211 | 260 | 43 | $190K |
| Gabapentin Generic | 209 | 332 | 69 | $2,324 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 208 | 222 | 46 | $130K |
| Pantoprazole Sodium Generic | 207 | 431 | 70 | $1,941 |
Brand drugs: 2,639 claims; generic drugs: 7,310 claims; opioid claims: 252.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Isabel Y Lee $3,385 ($3,385 in general payments such as food, travel and fees) from 25 companies. The largest payer was Amgen Inc. with $929.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 69 | $929 |
| Corcept Therapeutics CORT | 13 | $473 |
| Novo Nordisk Inc NVO | 24 | $309 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $227 |
| GlaxoSmithKline, LLC. GSK | 17 | $200 |
| Esperion Therapeutics, Inc. ESPR | 12 | $166 |
| Ardelyx, Inc. ARDX | 17 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $156 |
| Lilly USA, LLC LLY | 9 | $149 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $85.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.